Author

Natalia Navarro

Vall d'Hebron Institut de RecercaORCID 0000-0002-2160-6656Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Amelie S. WenziD· 1 shared Aroa SorianoiD· 1 shared Gabriel Gallo-OlleriD· 1 shared Gabriela GuilléniD· 1 shared Guillem PonsiD· 1 shared Jordi Carreras PuigvertiD· 1 shared Josep M RomaiD· 1 shared Josep Sánchez de Toledo· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amelie S. WenzORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Combined inhibition of MDM2 and PARP lead to a synergistic anti-tumoral response in p53 wild-type rhabdomyosarcoma models

Guillem Pons, Patricia Zarzosa, Gabriel Gallo-Oller, Amelie S. Wenz, Maris Lapins, Lia García-Gilabert, Júlia Sansa-Girona, Natalia Navarro, Miguel F. Segura, Aroa Soriano, Gabriela Guillén, Raquel Hladun, Josep Sánchez de Toledo, Soledad Gallego, Jordi Carreras Puigvert, , Josep M Roma

This study shows that combining MDM2 and PARP inhibitors synergistically inhibits p53 wild-type rhabdomyosarcoma growth in vitro and in vivo.

bioRxiv · Dec 3, 2024 · PreprintCancer Biology